A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer
ConclusionsThe combination of fractionated radiation and weekly full dose nab-paclitaxel was safe and well-tolerated.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Abraxane | Anemia | Borderline Tumor | Brain | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Drugs & Pharmacology | Gastroenterology | Laboratory Medicine | Neurology | Pancreas | Pancreatic Cancer | Study | Toxicology